Molecular crosstalk between cancer and neurodegenerative diseases

Area of Science:

• Molecular biology
• Neuroscience
• Oncology

Background:

• Cancer and neurodegenerative diseases share molecular determinants and deregulated pathways.
• Several key molecules, including p53, cyclins (D, E, F), Pin1, and protein phosphatase 2A, are implicated in both conditions.
• Intercellular communication within the brain's microenvironment links brain cancers and neurodegeneration.

Purpose of the Study:

• To review current knowledge on molecular determinants common to cancer and neurodegenerative disorders.
• To explore the distinct and overlapping pathways involving p53, cyclins, Pin1, and protein phosphatase 2A.
• To discuss the role of intercellular communication in brain cancers and neurodegeneration and potential therapeutic avenues.

Main Methods:

• Literature review and synthesis of existing research.
• Analysis of molecular pathways and protein functions.
• Discussion of intercellular signaling in the brain tumor microenvironment.

Main Results:

• Identified shared molecular players (p53, cyclins, Pin1, PP2A) in cancer and neurodegeneration.
• Highlighted distinct and overlapping functional pathways driven by these molecules.
• Emphasized the role of tumor-neuron communication in the brain's extracellular environment.

Conclusions:

• Shared molecular mechanisms offer potential for cross-disease therapeutic strategies.
• Targeting common pathways could lead to novel treatments for both cancer and neurodegenerative diseases.
• Further research into intercellular communication is crucial for developing integrated treatment approaches.